 | • レポートコード：MRC2203A806 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：食品 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界のアラキドン酸市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、由来別（動物、植物）分析、形態別（乾燥、液体）分析、用途別（食品・飲料、医薬品）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のアラキドン酸市場規模：由来別（動物、植物） ・世界のアラキドン酸市場規模：形態別（乾燥、液体） ・世界のアラキドン酸市場規模：用途別（食品・飲料、医薬品） ・世界のアラキドン酸市場規模：地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ） ・競争状況（Cargill. Inc、Cabio Biotech (Wuhan)Co., Ltd、Cayman Chemicals、...） ・市場機会・将来の傾向 |
Global arachidonic acid market is projected to grow with a CAGR of 6.8% during the forecast period (2019 – 2024).
Key Highlights
- The demand for ARA in dietary supplements is increasing, due to growing health awareness among consumers. With the growing outdoor sporting activities, including car racing and marathons, the possibility of physical injuries is expected to increase, which is likely to drive the market in terms of increasing applications, thus generating revenue.
- The growth of the market is majorly due to the increasing penetration of infant food formulas and also increased usage in sports nutrition.
- The ARA market is proportional to the increasing demand for omega-6 fatty acids in the food. This rise in demand is due to an increase in consumer awareness about the consumption of essential fatty acids and its associated benefits.
Key Market Trends
Application of ARA in Infant Formula Increases
The application of arachidonic acid in infant nutrition is expected to increase during the forecast period due to the rapid technological advancements and new patents recorded by the key players in the market. This is due to the need of omega-6 fatty acids in infants, as they cannot synthesize the required amount. Hence, the essential fatty acids are provided by the additional supplement of ARA in infant food. DHA and arachidonic acid (ARA), a 20-carbon fatty acid, are the key components that help the formation of cell membranes in infant’s brains. The amount of DHA and ARA in breast milk is highly variable among different countries and is dependent on a mother’s diet. During cases where the infant is not receiving the required amount of ARA, the latter can be provided in the form of ARA-supplemented formula, and eventually through solid foods.
North America holds the largest market share
The market is further segmented on the region basis into North America, Europe, Asia Pacific, Africa, and South America. North America holds the largest share of the arachidonic acid market in food applications followed by Europe and Asia- Pacific. The EU regulatory environment has supported the market growth in the region. This is due to the presence of many companies and intense R&D activities carried out with many new patents using ARA for infant formula, as well as sports nutrition and the growing fertility rate in the North American, especially in Mexico, enables for the market growth for the ARA in infant formula. The recent trend of using ARA for curing diabetes is expected to contribute to the market growth in other North American countries.
Competitive Landscape
The key players in the arachidonic acid market include Galactic, Cargill, Purac, ADM, Henan Jindam Arachidonic acid Co., Ltd., and Corbion, amongst others. The major competitors prefer investment in new product development and marketing strategy due to volatility in commodity costs to maintain their position.
June 2016- Arcadia Biosciences, Inc. and DuPont Pioneer have announced a successful field trial safflower plants which can produce high levels of arachidonic acid (ARA) oil. This key milestone is a major step towards developing a new plant-based and cost-effective source of oil with high levels of ARA.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Source
5.1.1 Animal
5.1.2 Plant
5.2 By Form
5.2.1 Dry
5.2.2 Liquid
5.3 By Application
5.3.1 Food and Beverage
5.3.1.1 Infant Formula
5.3.1.2 Dietary Supplements
5.3.2 Pharmaceuticals
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.1.4 Rest of North America
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 Italy
5.4.2.4 France
5.4.2.5 Russia
5.4.2.6 Spain
5.4.2.7 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 India
5.4.3.2 China
5.4.3.3 Australia
5.4.3.4 Japan
5.4.3.5 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle East and Africa
5.4.5.1 South Africa
5.4.5.2 Saudi Arabia
5.4.5.3 Rest of Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Share Analysis
6.2 Company Profiles
6.2.1 Cargill. Inc
6.2.2 Cabio Biotech (Wuhan)Co., Ltd
6.2.3 Cayman Chemicals
6.2.4 Guangdong Runke
6.2.5 Koninklijke DSM N.V.
6.2.6 A & Z Food Additives Co., Ltd
6.2.7 Merck Group
6.2.8 Wuhan Shu Ou Technology Co.,Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS